Gemini Bioproducts LLC
West Sacramento, CA Doing business as Gemini Bio Products
- UEI
- TPLGWKT6AM88
- CAGE
- 1MH12
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 920 Stillwater Rd #130, West Sacramento, CA 95605, USA
- Website
- geminibio.com
- Founded
- 1985
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Gemini bioproducts, LLC:1110293 [25-003371] description: 01-gemcell plus xeno free lot H424023 units: each catalog #:… | NIH Clinical Center | $63,530 | |
| Gemini bioproducts (ambis #2231103) | National Institute of Allergy and Infectious Diseases | $79,875 | |
| Gemcell plus xeno freelot H423031 | NIH Clinical Center | $61,728 | |
| Benchmark fetal bovine serum (ambis #2187095) | National Institute of Allergy and Infectious Diseases | $24,807 | |
| Fetal bovine serum, US origin FBS) (ambis #2180219) | National Institute of Allergy and Infectious Diseases | $19,255 |
About Gemini Bioproducts LLC
Gemini Bioproducts LLC is a for-profit corporate entity based in West Sacramento, California, specializing in the manufacture and supply of cell culture products, media, sera, and related scientific reagents. Registered in SAM.gov since 2001, the company has established itself as a key supplier to federal research institutions, particularly within the biomedical research ecosystem. The company provides critical biological products used in scientific research, medical testing, and emergency response efforts, with a notable track record of supplying high-quality cell culture materials to various federal agencies.
The company has consistently received federal contract awards primarily from agencies within the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Heart Lung and Blood Institute. Gemini Bioproducts' primary offerings include fetal bovine serum, cell culture media, viral transport media, and specialized biological reagents. Most of their contracts are firm fixed-price purchase orders without specific set-aside designations, though one recent contract was designated for small businesses. Their products have been crucial in supporting research on infectious diseases, including significant contributions to COVID-19 research, with contracts involving the procurement of products like GemCell Plus Xeno Free cell culture media, benchmark fetal bovine serum, and other specialized research materials.
Gemini Bioproducts holds two significant indefinite delivery/indefinite quantity (IDIQ) contracts that demonstrate their strategic importance to federal emergency response and research efforts. The first is a $200 million multiple-award IDIQ contract with the Federal Emergency Management Agency (FEMA) for COVID-19 testing supplies, which enabled rapid procurement of saline tubes and viral transport media during the pandemic. The second is a $100 million single-award Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations, providing cell culture products, sera, antibiotics, media, reagents, and blood-related products. These contracts underscore the company's capability to quickly respond to urgent national needs, particularly in biomedical research and emergency response scenarios, with a proven ability to deliver specialized scientific supplies across multiple federal agencies.
Contract vehicles
SBA capabilities narrative
Gemini Bio-Products founder Bert Polan recognized early on in the 1980's that the cell culture industry would continue to play an integral role in medical research and development. Our emerging company's focus and niche was-and still is-producing consistent, high quality products, coupled with exceptional, personalized service to our clients. Gemini has consistently been able to provide a high level of service throughout its 30 year history. Samples and orders are often processed and shipped the same day they are requested, enabling the customer to receive next-day service. Our sales staff visits clients on a regular basis to mutually determine how best their needs can be met.
Quick answers
What is Gemini Bioproducts LLC's UEI?
Gemini Bioproducts LLC's Unique Entity ID (UEI) in SAM.gov is TPLGWKT6AM88.
What is Gemini Bioproducts LLC's CAGE code?
Gemini Bioproducts LLC's CAGE code is 1MH12.
What is Gemini Bioproducts LLC's primary NAICS code?
Gemini Bioproducts LLC's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Gemini Bioproducts LLC located?
Gemini Bioproducts LLC's physical address in SAM.gov is 920 Stillwater Rd #130, West Sacramento, CA 95605, USA.
Is Gemini Bioproducts LLC registered in SAM.gov?
Yes. Gemini Bioproducts LLC's SAM.gov registration is active through August 21, 2027.
Which contract vehicles does Gemini Bioproducts LLC hold?
Gemini Bioproducts LLC holds a place on 1 federal contract vehicle: Swabs and Media in Support of COVID-19 Response.
What is Gemini Bioproducts LLC's most recent federal award?
Gemini Bioproducts LLC's most recent federal contract award is Gemini bioproducts, LLC:1110293 [25-003371] description: 01-gemcell plus xeno free lot H424023 units: each catalog #:… (75N90025P00190), from NIH Clinical Center, on February 14, 2025.
On GovTribe
See Gemini Bioproducts LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors